Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study.

Rongrui LiuLianke LiuChuanhua ZhaoYuxian BaiYulong ZhengShu ZhangNing LiJianwei YangQingxia FanXiuwen WangShan ZengYingjun ZhangWeihong ZhangYulei ZhuangNing KangYingzhi JiangHongmei SunJian-Ming Xu

Published in: BMC gastroenterology (2021)

This trial was retrospectively registered on 25/03/2019, NCT03888092. https://clinicaltrials.gov/ct2/show/NCT03888092 .

Keyphrases

epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
computed tomography
clinical trial
cell proliferation
study protocol
image quality
contrast enhanced
phase iii
cross sectional
dual energy
nucleic acid
positron emission tomography